Aminolabs has undergone a management buy-out supported by LRM as it aims to enhance innovation and sustain growth in the competitive dietary supplement market.

Target Information

Aminolabs, established thirty years ago, has emerged as a leading global player in the high-quality sports nutrition and dietary supplements sector. In 2015, Waterland Private Equity acquired a majority stake in Aminolabs, marking the initiation of a significant structural growth phase for the company. Under Waterland's guidance, Aminolabs expanded through multiple acquisitions both domestically and internationally, solidifying its position as a top-tier contract manufacturer for powders, capsules, and tablets.

As a prominent supplier in the sports nutrition and dietary supplement market, Aminolabs has diversified its product offerings to include functional food bars, which led to the establishment of a separate entity, EMPWR, in 2020. This spin-off has proven successful, generating over 160 million euros in revenue in 2022. Roger Anné and Waterland Private Equity remain key shareholders in EMPWR, demonstrating their continued commitment to the sector.

Industry Overview

The dietary supplement industry in which Aminolabs operates has witnessed substantial growth over recent years. The market dynamics have evolved, with a shift in focus from solely athletes to a broader audience that include